Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > News > AIOCD Urges PM Modi to Shut Down Illegal E-Pharmacies! Cites Rising Antibiotic Resistance Crisis

AIOCD Urges PM Modi to Shut Down Illegal E-Pharmacies! Cites Rising Antibiotic Resistance Crisis

Published: January 6, 2026
SHARE

The All India Organisation of Chemists and Druggists (AIOCD), representing over 12 lakh licensed chemists, has written to Prime Minister Narendra Modi demanding immediate shutdown of illegal e-pharmacies. The letter highlights unregulated online sales of prescription antibiotics fueling antimicrobial resistance (AMR) a growing public health threat referenced in the PM’s recent Mann Ki Baat address based on ICMR findings.

Glimpse:

AIOCD accuses certain platforms of violating the Drugs and Cosmetics Act by dispensing antibiotics without valid prescriptions, often through dubious telemedicine consultations. This promotes self-medication, reducing treatment efficacy for common infections like pneumonia and UTIs. The body offers cooperation for enforcement while warning of worsening AMR, higher costs, and healthcare strain without swift action. The Delhi High Court has previously deemed e-pharmacies illegal, yet violations

The All India Organisation of Chemists and Druggists (AIOCD) has escalated its long-standing campaign against illegal online pharmacies by directly appealing to Prime Minister Narendra Modi for urgent intervention. In a letter signed by President J.S. Shinde and General Secretary Rajiv Singhal, the organization representing more than 12 lakh licensed chemists and druggists calls for the immediate closure of platforms operating outside legal bounds, citing direct links to India’s escalating antimicrobial resistance (AMR) crisis.

The plea references the Prime Minister’s recent Mann Ki Baat address, where he highlighted ICMR findings on unchecked antibiotic misuse. AIOCD argues that illegal e-pharmacies exacerbate this by enabling self-medication: “The indiscriminate use of antibiotics through self-medication is reducing the effectiveness of treatments for common infections, including pneumonia and urinary tract infections.”

Key accusations include:

Violation of the Drugs and Cosmetics Act, 1940, by supplying Schedule H/H1 drugs without legitimate prescriptions.

Misuse of telemedicine guidelines, where brief, unfamiliar consultations lead to prescriptions based solely on oral requests.

Inadequate enforcement despite the Delhi High Court’s observation that e-pharmacies are illegal.

AIOCD warns that delays risk treatment failures, overburdened healthcare infrastructure, and soaring costs urging: “Antibiotics should only be used when supported by a valid medical prescription.”

The organization extends an offer for “structured cooperation” with authorities to ensure compliance, positioning licensed chemists as partners in safeguarding public health.

This letter builds on AIOCD’s prior advocacy, including demands to withdraw draft notifications (GSR 817/E and 220/E) perceived as enabling unregulated sales. It reflects ongoing tensions between traditional retail chemists and digital platforms amid India’s booming but controversial e-pharmacy segment.

“The indiscriminate use of antibiotics through self-medication is reducing the effectiveness of treatments Antibiotics should only be used when supported by a valid medical prescription.”

By

HB Team

Related News

SwishX Launches Agentic AI Platform for Pharma and MedTech, Secures $2.2 Million Seed Funding

May 13, 2026

Sanofi India and NHM Madhya Pradesh Join Forces to Expand Rare Disease & NCD Care

May 11, 2026

NIPER Raebareli Partners with Lofty Laboratories to Accelerate Pharma Innovation in India

May 11, 2026

Genient Partners with AIT Biotech to Accelerate Clinical Genomics Expansion

May 5, 2026

Metropolis Introduces Breakthrough Blood Test for Early Alzheimer’s Detection

April 29, 2026

Cohance Lifesciences Bets Big on Leadership with Umang Vohra at the Helm

April 27, 2026

₹2,000 Cr Push to Turn Uttar Pradesh into India’s Next Pharma Manufacturing Hub

April 27, 2026

Quadria Capital Eyes ₹4,500 Cr Bet on Samarth Lifesciences

April 27, 2026

NIPER Hajipur & Boehringer Ingelheim Join Forces to Fast Track Drug Innovation

April 27, 2026

Sun Pharma’s $13 Billion Bet: A Bold Move to Dominate Global Pharma

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

India–UK Biotech Corridor Launched to Power Next Wave of Life Sciences Innovation

April 23, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Eli Lilly Strikes $7B Deal to Supercharge Next Gen Cancer Therapies

April 22, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

Siemens Healthineers Explores Karnataka Partnership to Build Future Ready HealthTech Hubs

April 18, 2026

Eli Lilly Eyes Kelonia Buyout to Accelerate Next Gen Cancer Therapies

April 20, 2026
Infinite Computer Solutions Launches Epic-Focused Center of Excellence in Dubai to Accelerate Middle East Healthcare Digitisation
CrisprBits Bags $3 M to Scale CRISPR-Powered Diagnostics & Genome Solutions
Microsoft and INBRAIN Team Up to Build Agentic AI for Brain-Computer Interfaces
MultiCare Health System Chooses Ambience Healthcare for Enterprise-Wide Ambient AI Rollout After Rigorous Head-to-Head Evaluation
Google Pulls AI-Generated Health Overviews After Experts Raise Serious Patient Safety Concerns
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?